Edition:
United Kingdom

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

6.34USD
14 Dec 2018
Change (% chg)

$-0.50 (-7.31%)
Prev Close
$6.84
Open
$6.76
Day's High
$6.85
Day's Low
$6.22
Volume
7,528
Avg. Vol
21,233
52-wk High
$19.00
52-wk Low
$6.22

Chart for

About

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. The Company is developing a portfolio of novel product candidates, including SPR994, Potentiator Platform (SPR741 and SPR206), and SPR720.... (more)

Overall

No Ratios Available.

Financials

  SPRO.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -- -- --
ROI: -- 9.01 14.96
ROE: -- 10.15 16.52

Earnings vs. Estimates